Technology, Disruptive Innovation and Partnerships that are revolutionizing How Medicines Are Made January 27th at 12:30pm
Join us for a panel discussion on January 27th at 12:30pm, “Technology, Disruptive Innovation and Partnerships that are revolutionizing How Medicines Are Made“,moderated by our very own David DiGiusto, CTO of Cell and Gene Therapy. Panelists will include an array of industry experts including Resilience team members: Bruce Thompson., VP & Technical Lead, Cell Therapy and John Kerwin, Senior Director & Technical Head, Gene Therapy.
The technology of manufacturing complex medicines like cell and gene therapy hasn’t kept pace with the wave of scientific discoveries fueling them. Because many of these approaches to attacking diseases are so new, the process of making them hasn’t progressed beyond methods only meant for small batch, academic labs. In this panel discussion, we will take a deeper look into what has hindered growth and scalability of these medicines, and how disruptive technology and cross-industry partnerships are driving change in this young and exciting field of medicine.
Best practices for successful partnerships between industry, clients, service providers, technology partners, and academia
Viral vaccine technology platforms
Investment and risk-sharing in development
Product life cycle management
Anytime during the week, stop by our booth (#201) to learn how we can help you by revolutionizing the way medicines are made.